In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...

Delray Beach, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for accelerated innovation The ...

Chemical synthesis and peptide ligation techniques have revolutionised the field of protein engineering by enabling the precise construction of peptides and proteins with tailored modifications. These ...

The Peptide-Builder is designed for peptide chemists who want to make high-quality peptides quickly and easily at a laboratory scale. Peptides are synthesized sequentially and fully automated either ...

A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...

BERLIN, April 22, 2020 (GLOBE NEWSWIRE) -- JPT Peptide Technologies (JPT) announces the launch of ready-to-use peptide tools to study and profile the immune response towards SARS-CoV-2 infection. The ...

Vapourtec's Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesizer, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Peptide Microarray Market is valued at USD 903.8 million in 2025 and is projected to reach USD 1,316.4 million by 2035, expanding at a 3.8% CAGR. Growth is ...

Ottawa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The global chemical synthesis peptide drugs market size is calculated at USD 2.74 billion in 2025 and is expected to reach around USD 4.82 billion by 2034, ...

What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers of two to perhaps 48 residues, are not ...